Cargando…
Two-step cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei with high peritoneal carcinomatosis index
BACKGROUND: Complete cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) is the only curative treatment for pseudomyxoma peritonei (PMP) arising from the appendix. High peritoneal carcinomatosis index (PCI) is associated with an increased risk of surgical comp...
Autores principales: | Trilling, Bertrand, Brind’Amour, Alexandre, Hamad, Raphael, Tremblay, Jean-Francois, Dubé, Pierre, Mitchell, Andrew, Sidéris, Lucas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7903627/ https://www.ncbi.nlm.nih.gov/pubmed/33622339 http://dx.doi.org/10.1186/s12957-021-02171-z |
Ejemplares similares
-
Hyperthermic intraperitoneal chemotherapy with oxaliplatin as treatment for peritoneal carcinomatosis arising from the appendix and pseudomyxoma peritonei: a survival analysis
por: Marcotte, Eric, et al.
Publicado: (2014) -
A rare case of recurrent epidermoid anal cancer treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy—case report
por: Pravong, Vera, et al.
Publicado: (2020) -
Pregnancy after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Pseudomyxoma Peritonei
por: Campanati, Renato Gomes, et al.
Publicado: (2014) -
Recurrence of pseudomyxoma peritonei after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
por: Mercier, F., et al.
Publicado: (2018) -
The Impact of Computed Tomography Measurements of Sarcopenia on Postoperative and Oncologic Outcomes in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
por: Al Khaldi, Maher, et al.
Publicado: (2022)